Literature DB >> 31778766

The role and pharmacological properties of the P2X7 receptor in neuropathic pain.

Wen-Jun Zhang1, Zheng-Ming Zhu2, Zeng-Xu Liu3.   

Abstract

Neuropathic Pain (NPP) is caused by direct or indirect damage to the nervous system and is a common symptom of many diseases. Clinically, drugs are usually used to suppress pain, such as (lidocaine, morphine, etc.), but the effect is short-lived, poor analgesia, and there are certain dependence and side effects. Therefore, the investigation of the treatment of NPP has become an urgent problem in medical, attracting a lot of research attention. P2X7 is dependent on Adenosine triphosphate (ATP) ion channel receptors and has dual functions for the development of nerve damage and pain. In this review, we explored the link between the P2X7 receptor (P2X7R) and NPP, providing insight into the P2X7R and NPP, discussing the pathological mechanism of P2 X7R in NPP and the biological characteristics of P2X7R antagonist inhibiting its over-expression for the targeted therapy of NPP.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosine triphosphate (ATP); Antagonist; Nerve injury; Neuropathic pain (NPP); P2X7 receptor (P2X7R)

Mesh:

Substances:

Year:  2019        PMID: 31778766     DOI: 10.1016/j.brainresbull.2019.11.006

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  13 in total

Review 1.  Association between the rs3751143 polymorphism of P2RX7 gene and chronic lymphocytic leukemia: A meta-analysis.

Authors:  Wen-Jun Zhang; Zheng-Ming Zhu
Journal:  Purinergic Signal       Date:  2020-10-07       Impact factor: 3.765

2.  Dorsal root ganglia P2X4 and P2X7 receptors contribute to diabetes-induced hyperalgesia and the downregulation of electroacupuncture on P2X4 and P2X7.

Authors:  Qun-Qi Hu; Xiao-Fen He; Yi-Qi Ma; Li-Qian Ma; Si-Ying Qu; Han-Zhi Wang; Yu-Rong Kang; Lu-Hang Chen; Xiang Li; Bo-Yu Liu; Xiao-Mei Shao; Jun-Fan Fang; Yi Liang; Jian-Qiao Fang; Yong-Liang Jiang
Journal:  Purinergic Signal       Date:  2022-02-26       Impact factor: 3.765

3.  Activation of the P2X7 receptor in the dental pulp tissue contributes to the pain in rats with acute pulpitis.

Authors:  Zhi Xiao; Min Xu; Lan Lan; Ke Xu; Yue-Rong Zhang
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

Review 4.  The Role of ATP Receptors in Pain Signaling.

Authors:  Kazuhide Inoue
Journal:  Neurochem Res       Date:  2022-01-30       Impact factor: 4.414

5.  Protective effects of dihydromyricetin on primary hippocampal astrocytes from cytotoxicity induced by comorbid diabetic neuropathic pain and depression.

Authors:  Huixiang Ge; Mengyun Sun; Xingyu Wei; Mingming Zhang; Hongcheng Tu; Yuanzhen Hao; Ruxin Chen; Miao Ye; Yun Gao
Journal:  Purinergic Signal       Date:  2020-11-06       Impact factor: 3.765

Review 6.  Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy.

Authors:  Wen-Jun Zhang
Journal:  Purinergic Signal       Date:  2021-01-09       Impact factor: 3.765

Review 7.  P2X7 receptor: a critical regulator and potential target for breast cancer.

Authors:  Xiaodi Zhu; Qianqian Li; Wei Song; Xiaoxiang Peng; Ronglan Zhao
Journal:  J Mol Med (Berl)       Date:  2021-01-23       Impact factor: 4.599

Review 8.  Modulation of Pathological Pain by Epidermal Growth Factor Receptor.

Authors:  Jazlyn P Borges; Katrina Mekhail; Gregory D Fairn; Costin N Antonescu; Benjamin E Steinberg
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

9.  Dissection of P2X4 and P2X7 Receptor Current Components in BV-2 Microglia.

Authors:  Mira Trang; Günther Schmalzing; Christa E Müller; Fritz Markwardt
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

10.  The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib-Induced Neuropathic Pain.

Authors:  Yan Guo; Xiaobo Xu; Jingyi Huang; Zhen Wang; Zhenzhong Li; Zhen Liu
Journal:  Biomed Res Int       Date:  2020-07-14       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.